SAVIENT PHARMACEUTICALS, INC

SAVIENT PHARMACEUTICALS, INC
Share
We are a specialty biopharmaceutical company focused on commercializing KRYSTEXXA® in the United States and completing the development and seeking regulatory approval outside the United States.  KRYSTEXXA was approved by the FDA on September 14, 2010 and became commercially available in the United States by prescription on December 1, 2010.